Skin antisepsis in the neonate: what should we use?

被引:33
|
作者
Ponnusamy, Vennila [1 ]
Venkatesh, Vidheya [2 ]
Clarke, Paul [1 ]
机构
[1] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Neonatal Unit, Norwich NR4 7UY, Norfolk, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Neonatal Unit, Cambridge, England
关键词
microbiome; necrotizing enterocolitis; health; neonatal; infection; BIRTH-WEIGHT INFANTS; 10-PERCENT POVIDONE-IODINE; BLOOD-STREAM INFECTIONS; CHLORHEXIDINE GLUCONATE; RANDOMIZED-TRIAL; CHEMICAL BURNS; ALCOHOL BURNS; CARE; PREVENTION; SEPSIS;
D O I
10.1097/QCO.0000000000000064
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Neonates in intensive care are more susceptible to sepsis. Infection is commonly acquired via the transcutaneous portal. It is necessary to identify the most effective yet safest topical antiseptics for use in neonates to reduce nosocomial sepsis. Recent findings Recent national surveys indicate that a wide range of topical antiseptic preparations are used in the neonatal nursery. There are very few comparative studies in neonates and no robust evidence in favour of any particular antiseptic. There are significant safety and potential toxicity issues for neonates with all the commonly used antiseptics, particularly in very small immature babies. There are no convincing roles for routine application of emollient creams on the skin, topical antiseptics on the umbilical stump, or maternal vaginal washes with chlorhexidine for the prevention of neonatal infection. Summary Large multicentre trials are needed to determine the optimal antiseptic to use for neonates undergoing intensive care, especially for extremely preterm infants..
引用
收藏
页码:244 / 250
页数:7
相关论文
共 50 条
  • [1] Supporting hemodynamics: what should we target? What treatments should we use?
    Gattinoni, Luciano
    Carlesso, Eleonora
    [J]. CRITICAL CARE, 2013, 17
  • [2] Supporting hemodynamics: what should we target? What treatments should we use?
    Luciano Gattinoni
    Eleonora Carlesso
    [J]. Critical Care, 17
  • [3] Skin antisepsis: it's not only what you use, it's the way that you use it
    Casey, A. L.
    Badia, J. M.
    Higgins, A.
    Korndorffer, J.
    Mantyh, C.
    Mimoz, O.
    Moro, M.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2017, 96 (03) : 221 - 222
  • [4] Should we use a separate knife for the skin?
    Schindler, OS
    Spencer, RF
    Smith, MD
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2006, 88B (03): : 382 - 385
  • [5] Should olanexidine be used routinely for surgical skin antisepsis?
    Willy, Christian
    Vogt, Dennis
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (11): : 1219 - 1220
  • [6] Biodiversity: what value should we use?
    Hungate, Bruce A.
    Cardinale, Bradley J.
    [J]. FRONTIERS IN ECOLOGY AND THE ENVIRONMENT, 2017, 15 (06) : 283 - 283
  • [7] What is the Marshall Protocol -- and should we use it?
    Milman, Nils
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (04) : 319 - 320
  • [8] What reference doses should we use?
    J Brown
    [J]. British Dental Journal, 1999, 186 (8) : 385 - 385
  • [9] What are we? What should we be?
    Leung, Gabriel M.
    Gray, Selena
    [J]. JOURNAL OF PUBLIC HEALTH, 2012, 34 (04) : 475 - 476
  • [10] What we do, what we should do, and what we should not do
    Ernst, E
    [J]. ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2001, 7 (04) : 36 - +